What are the treatment options for a patient with osteoarthritis (OA) of the hands?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hand Osteoarthritis

Begin with non-pharmacological interventions as first-line therapy, specifically education on joint protection, custom-made thumb splints for CMC joint involvement, and exercises, then add topical NSAIDs before progressing to oral analgesics. 1, 2

First-Line Non-Pharmacological Management

All patients must receive education and self-management training as the foundation of treatment. 1, 2

  • Provide education on the nature and course of hand OA, self-management principles, and available treatment options 1, 2
  • Instruct in joint protection techniques to minimize stress on affected joints and avoid adverse mechanical factors 1, 3
  • Evaluate ability to perform activities of daily living and provide assistive devices as needed 1, 2

Splinting is essential for thumb base (first CMC joint) OA and should be custom-made for optimal compliance. 2, 3

  • Use neoprene or rigid orthoses for first CMC joint OA with long-term use (at least 3 months) for optimal symptom relief 2
  • Custom-made orthoses are preferred over prefabricated ones to ensure proper fit 2
  • For other hand joints, orthoses may be considered as disease progresses but with lower strength of recommendation 2

Exercise programs should target range of motion, strengthening, and thumb base stability. 1, 2, 3

  • Implement daily home exercise regimens involving both range of motion and strengthening exercises 2, 3
  • Tailor exercises specifically to joint involvement—CMC joint exercises differ from interphalangeal joint exercises 2

Heat therapy provides symptomatic relief and should be applied before exercise. 2, 3

  • Use local heat application (paraffin wax or hot packs) especially before exercise sessions 2, 3
  • Heat therapy has stronger evidence (77% recommendation strength) compared to ultrasound (25%) 2

First-Line Pharmacological Management

Topical NSAIDs are the preferred first pharmacological treatment due to superior safety profile, especially when only a few joints are affected. 1, 2, 3

  • Topical NSAIDs should be used before systemic treatments for mild to moderate pain 2, 3
  • Topical capsaicin is an alternative with NNT of 3 for moderate pain relief 1, 2, 3

Second-Line Pharmacological Management

Add acetaminophen (paracetamol) up to 4g/day as the oral analgesic of first choice when topical treatments are insufficient. 2, 3

  • Acetaminophen has 87-92% expert consensus as first-line oral analgesic 3

Third-Line Pharmacological Management

Use oral NSAIDs at the lowest effective dose for the shortest duration when acetaminophen provides inadequate relief. 1, 2, 3

  • In patients ≥75 years old, strongly prefer topical over oral NSAIDs due to safety concerns 1, 2
  • For patients with increased gastrointestinal risk, use non-selective NSAIDs plus gastroprotective agent or selective COX-2 inhibitor 2
  • Tramadol may be considered for inadequate response to other analgesics 1, 2

Management of Inflammatory Flares

Intra-articular corticosteroid injection is effective for painful flares, particularly in the trapeziometacarpal joint. 2, 3

  • Reserve for acute inflammatory episodes rather than routine management 2, 3

Surgical Intervention

Consider surgery (interposition arthroplasty, osteotomy, or arthrodesis) for severe thumb base OA with marked pain and/or disability when conservative treatments have failed. 2, 3

Critical Caveats and Common Pitfalls

Avoid intra-articular therapies and opioid analgesics in initial management of hand OA. 1, 2

  • Opioids are conditionally recommended against due to unfavorable risk-benefit profile 1, 2

Splinting requires consistent use for at least 3 months—shorter periods show minimal benefit. 2

Do not use conventional or biological disease-modifying antirheumatic drugs for hand OA. 2

Assess for comorbidities before finalizing treatment plan. 1

  • Screen for hypertension, cardiovascular disease, heart failure, gastrointestinal bleeding risk, and chronic kidney disease that impact pharmacologic safety 1

Address broader impact on quality of life with multimodal approach rather than single medication. 1

  • Consider mood disorders, altered sleep, chronic widespread pain, and impaired coping skills 1
  • Measures aimed at improving mood, reducing stress, addressing insomnia, and enhancing fitness improve overall well-being and treatment success 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hand Osteoarthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hand Arthritis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.